Many extremely preterm infants spend considerable time outside the intended arterial oxygen saturation range because of their respiratory instability and often insufficient or excessive oxygen supplementation, which increases the risk of complications associated with hypoxemia and hyperoxemia.
Most extremely preterm infants require supplemental oxygen for prolonged periods of time, which exposes them to increased risk for lung and eye injuries. 1, 2 Because of their respiratory instability, these infants spend considerable amounts of time outside the intended pulse oxygen saturation (SpO 2 ) range. Multicenter data showed that preterm infants receiving supplemental oxygen spent ϳ30% of the time above and 20% of the time below the center's intended SpO 2 range 3, 4 ; high SpO 2 levels are almost invariably caused by exposure to an unnecessarily high fraction of inspired oxygen (FIO 2 ). Many of these infants also present with frequent episodes of decreased SpO 2 , and delayed or insufficient adjustment of FIO 2 may result in prolonged periods of low SpO 2 . Conversely, excessive or extended increases in FIO 2 can produce rebound or prolonged hyperoxemia and augment oxygen exposure.
An algorithm for automated adjustment of FIO 2 was developed with the aim of improving maintenance of SpO 2 within an intended range for preterm infants undergoing mechanical ventilation. This algorithm was shown to be more effective than a bedside nurse fully dedicated to adjusting FIO 2 or the routine caregiver in maintaining SpO 2 within the intended range for preterm infants with frequent fluctuations in SpO 2 , for 2 and 4 hours, respectively. 5 Because of their relatively brief durations and because they were conducted with continuous investigator supervision of the automated system, those studies might not have truly assessed the effects of this automated system under routine clinical conditions, and they did not assess possible interactions with staff members during NICU care. The objective of this multicenter crossover study was to evaluate, in the routine clinical environment of the NICU, the efficacy and safety of automated FIO 2 adjustment in maintaining SpO 2 within an intended range, for preterm infants with frequent spontaneous fluctuations in SpO 2 .
METHODS

Study Design and Subjects
The study was conducted at level III NICUs at the University of Miami/Jackson Memorial Hospital (Miami, FL), Ohio State University/Nationwide Children's Hospital (Columbus, OH), the University of Southern California/Los Angeles County-University of Southern California Women's and Children's Hospital (Los Angeles, CA), and the University of Michigan/C. S. Mott Children's Hospital (Ann Arbor, MI). The study was approved by the institutional review boards, and written informed parental consent was obtained for enrollment.
Preterm infants requiring mechanical ventilation and supplemental oxygen were eligible if they exhibited Ն4 spontaneous episodes with SpO 2 of Ͻ80% during an 8-hour period, within 24 hours before the study. Infants with major congenital anomalies, hemodynamic instability, seizures, or ongoing sepsis or meningitis were excluded. On the basis of a previous study comparing this automated system with the routine caregiver for 4 hours, 6 it was estimated that enrollment of 30 infants would be needed to detect an 8% increase in the time within the intended SpO 2 range, with power of 90% and ␣ of 5%.
Automated FIO 2 System
The system consisted of an infant ventilator (Avea [ remained outside the alarm limits for a set time (Ͻ85% or Ͼ94% for Ն120 seconds), FIO 2 reached a high or low level (1.0 or 0.21, respectively), or there was an increase of Ն0.3 in the basal FIO 2 . The pulse oximeter was set at normal sensitivity, with an averaging interval of 8 seconds, and the alarm was set to activate with SpO 2 values of Ͻ85% or Ͼ94% for Ͼ10 seconds. The probe (LNOP Neo-L [Masimo]) was placed on the right upper extremity. If this was not possible, then the probe was placed on the extremity where SpO 2 was measured before the study. Extremities with a blood pressure cuff or with poor perfusion were avoided. If the SpO 2 signal was lost because of probe disconnection or artifact for Ͼ10 seconds or the oximeter indicated poor SpO 2 signal quality for Ͼ120 seconds, then the automated function adopted a fail-safe state and FIO 2 was set at the median level of the preceding 15 seconds of valid data. The automated function was programmed to pause when the ventilator feature of a 2-minute increase in FIO 2 for procedures or suction was used. In this study, this feature was set to provide an increase in FIO 2 of 0.2.
Protocol
The study consisted of 2 consecutive periods, that is, a 24-hour period with FIO 2 adjustment by clinical staff members (manual) and a 24-hour period with automated FIO 2 adjustment (automated). The sequence of the manual and automated periods was assigned at random to each infant, in blocks according to center. Sequence assignments were kept in sealed opaque envelopes that were opened at the bedside before the start of the study for each individual infant.
Clinical staff members at each center were informed of the study objectives and procedures, including the intended SpO 2 range (87%-93%) and alarm limits (85%-94%), before the start of enrollment. Before the 24-hour manual period, nurses and respiratory therapists were instructed to adjust FIO 2 , as performed routinely in their centers, to maintain SpO 2 within the intended range. The staff members also were instructed to respond to high SpO 2 alarms (Ͼ94%) by weaning FIO 2 as usually performed in their centers and to provide additional oxygen during low SpO 2 alarms (Ͻ85%) by adjusting the FIO 2 dial or the 2-minute FIO 2 increase function. Nursing and respiratory staff members were educated regarding the use of the automated FIO 2 function and associated warnings and alarms. Before the automated period, clinical staff members were given the option to conduct patient care procedures with assistance from the automated FIO 2 function or to pause it and to adjust FIO 2 manually as needed.
There was a 1:2 nurse/patient ratio in all participating centers. The research team was available for consultation at all times. The variability in SpO 2 was assessed by calculating the coefficient of variation over the 24-hour periods and by assessing data on the frequency and duration of episodes with SpO 2 below the intended range (episodes with SpO 2 of Ͻ87% and Ͻ75% for Ն10 seconds) and episodes with SpO 2 above the intended range (episodes with SpO 2 of Ͼ93% and Ͼ98% for Ն10 seconds). Prolonged episodes of decreased SpO 2 below the alarm limit, defined as SpO 2 of Ͻ85% for Ͼ120 seconds or SpO 2 of Ͻ75% for Ͼ60 seconds. Episodes of bradycardia (heart rate of Ͻ100 beats per minute for Ն10 seconds), were counted for each 24-hour period.
Data Collection and Analysis
Hourly median SpO 2 and FIO 2 values were calculated for every hour of the 24-hour study periods for each infant. The 24-hour median FIO 2 over the entire period and the time with FIO 2 of Ͻ0.25 were calculated for each study period. The numbers of manual changes to the FIO 2 dial or key presses to increase FIO 2 for 2 minutes during the manual and automated periods were counted.
To account for periods when SpO 2 improved and infants did not require supplemental oxygen, the combined measure of time with SpO 2 within the intended range (87%-93%) plus time with SpO 2 of Ͼ93% with FIO 2 of 0.21 was calculated. The combined measure of time with SpO 2 within alarm limits (85%-94%) plus time with SpO 2 of Ͼ94% with FIO 2 of 0.21 was calculated to assess whether the staff members were more effective in keeping SpO 2 values within the alarm limits than in keeping them within the intended range. To assess overshoot in the manual and automated responses to episodes with SpO 2 of Ͻ87%, episodes that were followed by SpO 2 values Ͼ93% for Ͼ60 seconds during the 2 minutes after the episode were counted (reported as proportion of all episodes with SpO 2 of Ͻ87%).
Intention-to-treat analysis was applied to all recorded data for both 24-hour periods, and times during the automated period when the automated system was paused were not excluded from the analyses. Statistical analyses consisted of within-subject comparisons with paired t tests for normally distributed data or nonparametric Wilcoxon signed rank tests. Results are reported as mean Ϯ SD or median and interquartile range. Within-subject comparisons over time were conducted with 2-factor, repeatedmeasures, analyses of variance, with the Holm-Sidak method for posthoc pairwise comparisons. P values of Ͻ.05 were considered statistically significant.
Data and Safety Monitoring
Monitored adverse events included prolonged hypoxemia (SpO 2 of Ͻ85% for Ͼ10 minutes) despite an increase in FIO 2 of Ͼ0.2 from baseline, increase in basal FIO 2 above 0.6, prolonged hypoventilation (Ͼ10 minutes) attributable to an absence of spontaneous breathing or worsening lung function leading to an increase in FIO 2 of Ͼ0.2 to maintain SpO 2 Ͼ85% or blood gas analyses showing PaCO 2 of Ͼ80 mm Hg or value increased by 15 mm Hg, hypotension with mean arterial pressure of Ͻ30 mm Hg, and Ն2 episodes of bradycardia (heart rate of Ͻ100 beats per minute) per hour. The attending physician could remove the infant from the study if the condition did not resolve with corrective measures. Protocol violations monitored during the study included but were not limited to inappropriate setting or pausing of the automated FIO 2 function, incorrect setting of the SpO 2 monitor, and premature and unjustified exit from the study.
A 3-member independent data and safety monitoring board could recommend termination of the study at 50% enrollment if adverse events suggested undue risk, the primary outcome measure results were significantly worse during the automated period, futility was demonstrated, or protocol violations compromised scientific validity. A clinical monitor appointed by the sponsor oversaw compliance with the protocol and human subject research and regulatory rules.
RESULTS
Thirty-five infants who were undergoing mechanical ventilation, required supplemental oxygen, and exhibited frequent spontaneous episodes of decreased SpO 2 were enrolled between February and September 2008. One infant who met exclusion criteria before the study was enrolled inadvertently. This infant exhibited clinical deterioration shortly after the start of the study and was withdrawn by the investigator; this was considered unrelated to the study. Thirty-four infants completed both 24-hour periods without adverse events. Two of these infants were excluded because of missing data resulting from an electronic datalogging failure. There were study protocol violations for 5 infants. For 2 infants, the upper limit of the intended SpO 2 range was set at 95% instead of 93% for part of the automated period. For 3 infants, when basal FiO 2 values were between 0.22 and 0.3, SpO 2 alarm limits were set above the protocol's alarm limits for part of the 24-hour period. The infants with protocol violations were not excluded from the intention-to-treat analyses.
Data for 32 infants who completed both 24-hour periods were analyzed. Demographic characteristics and ventilator settings for these infants are shown in Table 1 . Eleven infants were receiving caffeine and 10 infants were receiving low doses of sedatives at the time of the study. These treatments did not change during the course of the study.
Sixteen infants were assigned randomly to start with the 24-hour manual period, followed by the 24-hour automated period, and 16 infants were assigned to the opposite sequence. The ventilator mandatory rate, peak pressure, positive end-expiratory pressure, pressure support, and mean airway pressure during the automated period did not differ from those during the manual period. Table 2 shows the proportion of time within different ranges of SpO 2 . The primary outcome measure, time with SpO 2 within the intended range of 87% to 93%, increased significantly during the automated period, compared with the manual period. During the automated period, there were significant Analysis of the data with the exclusion of the 5 infants for whom protocol violations occurred did not reveal disagreement with the findings in the intention-to-treat analyses. One-half of the infants underwent one of the sequences and the other one-half underwent the opposite sequence of the manual and automated periods. Group comparisons of treatment effects did not reveal carryover effects.
DISCUSSION
This multicenter study evaluated the short-term efficacy and safety of automated adjustment of FIO 2 in the routine NICU environment and the interaction with clinical staff members over a significant period of time and without continuous investigator presence. For full assessment of the effects on the maintenance of an intended SpO 2 range and the impact on personnel efforts, the study population included ventilated infants with frequent spontaneous episodes of decreased SpO 2 , a population that offers a special challenge during routine clinical care, as well as with the automated FIO 2 system.
The difficulty of maintaining SpO 2 for these infants is shown by the time in range during the manual period (32%).
Observational data obtained from all infants requiring supplemental oxygen showed that the proportion of time within range decreased from 51% in week 1 to 44% in week 4. 3 This study enrolled only infants with frequent fluctuations in SpO 2 , and the median age was 27 days. The time within range during the automated period (40%) was not strikingly different from that reported at 4 weeks, 3 despite being obtained with a challenging group of infants.
The primary outcome measure, time within the intended range of SpO 2 (87%-93%), was increased during the period with automated FIO 2 control, compared with the period with manual adjustment of FIO 2 . In addition, there was a substantial reduction in the time above the intended SpO 2 range and a striking reduction in the time with SpO 2 of Ն99% during the automated period. These reductions were accompanied by a consistently lower FIO 2 throughout the 24-hour automated period, compared with the 24-hour manual period. These reductions are important because of the association between oxygen exposure and lung and retinal injuries. 7 The increase in the time within the intended range observed in this study was smaller than may be considered clinically important. However, this must be considered in the context of the simultaneous reductions in high SpO 2 values, inspired oxygen concen- The eligibility criteria were defined to include infants with frequent episodes of hypoxemia, because they were considered a challenge to the automated and manual control of FIO 2 . Although postnatal age was not a criterion, 75% of the infants were Ͼ2 weeks of age and had required ventilation almost continuously before the study. The frequency of hypoxemia might have reflected their lung disease. Therefore, these findings cannot be extrapolated directly to preterm infants with fewer fluctuations in SpO 2 values or milder lung disease.
CONCLUSIONS
This multicenter crossover study, which was conducted over 24 hours under routine NICU conditions with infants with frequent fluctuations in SpO 2 showed that automatic FIO 2 adjustment improved maintenance of an intended SpO 2 range and reduced exposure to high SpO 2 values, the inspired oxygen concentration, and staff effort, compared with manual adjustment. These effects were accompanied by morefrequent episodes that increased the time with SpO 2 between 80% and 86%. The efficacy of automated FIO 2 adjustment for infants in more-stable condition who require less-invasive respiratory support, such as nasal continuous positive airway pressure therapy, still needs to be assessed. The extent to which improved maintenance of SpO 2 with reduced exposure to high SpO 2 and concentrations through automated FIO 2 adjustment can affect respiratory, ophthalmic, and neurologic outcomes for preterm infants remains to be examined.
